Pharmaceutical Executive June 4, 2024
Delivering better patient outcomes hinges on innovation and adaptability.
We are at the crossroads of transformative change in the ever-evolving life sciences landscape. The journey ahead promises not only technological advancements and groundbreaking innovations but also a fundamental shift toward patient-centric care.
For instance, the FDA recently announced a ‘Patient-Focused Drug Development’1 (PFDD) approach to systematically integrate patients’ experiences, perspectives, needs and priorities into the drug development and evaluation process. Why? By leveraging their personal experiences, patients play a unique and invaluable role in enhancing the understanding of the therapeutic context for drug development and evaluation. The insight from this data is invaluable.
Moreover, patients are well-informed and looking for hyper-personalized experiences that are secure, reliable and transparent — factors...
Today's Sponsors
Today's Sponsor